Registry of Lobbyists
Total Number of Communication Reports: 58
Monthly communication reports in the last 6 months: 0
Version 1 of 25 (2005-08-17 to 2006-02-24) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.
| Corporation: |
PURDUE PHARMA
575 Granite Court Pickering, ON L1W 3W8 Canada |
| Telephone number: | 905-420-4976 |
| Fax number: | 905-420-4193 |
| Responsible officer name and position during the period of this registration: | John Stewart, Executive Vice President and GM |
| Description of activities: | Purdue Pharma is engaged in the research, development, production and distribution of both prescription and over-the-counter medicines and hospital products. The company is particularly active in the area of drug delivery technologies, and markets products for the treatment of pain, respiratory disease, gastrointestinal disorders and infection control. |
| Parent: | The corporation is not a subsidiary of any other parent corporations. |
| Coalition | The corporation is not a member of a coalition. |
| Subsidiary: | The corporation does not have any subsidiaries that could be affected by the outcome of the undertaking. |
| Other direct interests | The corporation's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking. |
| Was the corporation funded in whole or in part by any domestic or foreign government institution in the last completed financial year? | No |
| Name: | Randy Steffan |
| Position title: | Director, Corporate Affairs and Communications |
| Public offices held: | No |
| Name: | John Stewart |
| Position title: | Executive Vice President and General Manager |
| Public offices held: | No |
| Federal departments or organizations which have been or will be communicated with during the course of the undertaking: | Aboriginal Affairs and Northern Development Canada, Correctional Service of Canada (CSC), Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB), Privy Council Office (PCO), Royal Canadian Mounted Police (RCMP) | ||||||
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format | ||||||
| Subject Matter: Areas of Concern: | Health, Industry, Intellectual Property, International Trade | ||||||
| Subject Matter: Retrospective: | Communication with the Patented Medicine Prices Review Board (PMPRB) regarding proposed amendments to the Patented Medicines (Notice of Compliance) Regulations. | ||||||
| Subject Matter: Prospective: | Health Canada: ongoing communications regarding risk management programs for controlled prescription drugs and Canada's Drug Strategy.PMPRB: review of pricing submissions for pharmaceutical products. | ||||||
Details Regarding the Identified Subject Matter
|
|||||||